Jasper van Grunsven
CIK: 0002154061
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VRTX
VERTEX PHARMACEUTICALS INC / MA
Officer
Discretionary Trading P&L
Holdings
About van Grunsven Jasper
van Grunsven Jasper (SEC CIK 0002154061) files insider reports with the SEC as EVP, CP and NPPO of VERTEX PHARMACEUTICALS INC / MA (VRTX).
Signal8 holds 2 ownership filings by van Grunsven Jasper (1 Form 3, 1 Form 4), filed on Sep 10, 2026. Those filings report 1 transaction, the latest on Sep 8, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on van Grunsven Jasper's filings is in BOSTON, MA.
Recent filings by van Grunsven Jasper
- Sep 8, 2026: Grant or award of VRTX shares (Form 4, code A).
Other insiders filing for VERTEX PHARMACEUTICALS INC / MA (VRTX)
- Brennan Daniel J., Director
- SACHS BRUCE I, Director
- Garber Alan M, Director
- Ambrose Kristen, SVP & Chief Accounting Officer
- Tatsis Ourania, EVP, Chief Reg. & Quality Off.
- Sachdev Amit, EVP Chief Patient & Ext Af Off